The International region is AstraZeneca’s largest, most diverse, and fastest-growing region, representing around one-third of total company revenue. Spanning more than 90 countries across five continents, it covers over 70% of the world’s population. International is not “Rest of World” — it is “Most of World” — and with that scale comes a profound responsibility to patients, as the burden of non-communicable disease and mortality is disproportionately high across our markets. International is a critical growth engine for AstraZeneca, delivering double-digit growth across all therapy areas and playing a central role in the company’s future success. We operate in a complex, rapidly evolving environment — and we are doubling down on growth and pipeline delivery to make Ambition 2030 a reality in International. At the heart of this is how we use AI, digital and data to transform our company, accelerate our science and maximize our impact for patients.

We ar...